Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2611-2620 of 2762 for

Edit search filters
  1. Inherited Breast Cancer Study

    Rochester, MN, Scottsdale/Phoenix, AZ, Jacksonville, FL

  2. Computerized Cognitive Test to Screen for Cognitive Changes in Patients with Multiple Myeloma

    Scottsdale/Phoenix, AZ

  3. Melanoma Registry

    Jacksonville, FL

  4. Male Breast Cancer: Understanding the Biology for Improved Patient Care

    Rochester, MN

  5. A Study for Germline Mutations of Patients with Phyllodes Tumors of the Breast

    Rochester, MN

  6. Tumor Molecular Analysis

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  7. A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System

    Rochester, MN

  8. Validation of a Blood Assay for the Detection of BRAF Mutation Status in Patients with Metastatic Melanoma

    Rochester, MN

  9. Detection of Circulating Biomarkers (Circulating Tumor Cells and Circulating Tumor DNA) in Patients with Head and Neck Carcinoma following Surgical Intervention

    Scottsdale/Phoenix, AZ

  10. A Study to Evaluate Magnetic Resonance Spectroscopy Diagnosis and Follow-up of IDH-mutant Glioma

    Rochester, MN

.

Mayo Clinic Footer